EFFECT OF TUMOR-NECROSIS-FACTOR ON ENZYMES OF GLUCONEOGENESIS IN THE RAT

被引:0
|
作者
YASMINEH, WG
THEOLOGIDES, A
机构
[1] HENNEPIN CTY MED CTR, DEPT MED, 701 PK AVE S, MINNEAPOLIS, MN 55455 USA
[2] UNIV MINNESOTA HOSP & CLIN, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA
[3] UNIV MINNESOTA, SCH MED, MINNEAPOLIS, MN 55455 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effect of human recombinant tumor necrosis factor (TNF)-alpha on enzymes of gluconeogenesis in the rat was investigated by determining the activity of glucose 6-phosphatase, fructose 1,6-diphosphatase (FDP), and phosphoenolpyruvate carboxykinase in the liver and kidney of fed and fasted rats. The activity of transaldolase in the pentose phosphate pathway was also measured. Starvation of rats for 24 hr resulted in a 1.6- to 3.1-fold increase in liver and kidney glucose 6-phosphatase and phosphoenolpyruvate carboxykinase (P less-than-or-equal-to 0.05), a decrease in liver and kidney FDP (P < 0.002), and an increase in liver and kidney transaldolase (P = 0.0001). Injection of 50 and 100-mu-g/kg-day of TNF for 5 days resulted in a significant (P less-than-or-equal-to 0.03) decrease in kidney FDP only. Injection of 100-mu-g/kg/day of TNF for 5 days with a 24-hr fast on Day 5 resulted in a significant (P = 0.04) increase in liver transaldolase, and a significant decrease in kidney FDP and phosphoenolpyruvate carboxykinase. Comparison of the enzyme activities of rats injected with 100-mu-g/kg/day of TNF for 5 days with those of their pair-fed control partners revealed additionally a significant decrease in glucose 6-phosphatase in the liver (P < 0.001). It is concluded that TNF administration in the rat has different effects on the enzymes of gluconeogenesis in the liver and kidney, and these effects differ from those seen in starved or tumor-bearing rats.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 50 条
  • [21] TUMOR-NECROSIS-FACTOR AND AIDS
    ROUBENOFF, R
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 61 (01): : 161 - 162
  • [22] CACHECTIN OR TUMOR-NECROSIS-FACTOR
    BANYARD, MRC
    AUSTRALIAN VETERINARY PRACTITIONER, 1987, 17 (01): : 41 - 42
  • [23] TUMOR-NECROSIS-FACTOR AND AIDS
    MUNOZ, RA
    MEDICINA CLINICA, 1995, 104 (01): : 29 - 36
  • [24] TUMOR-NECROSIS-FACTOR AND HYPERMETABOLISM
    SEATON, TB
    COOMBE, N
    MITTELMAN, A
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) : 715 - 716
  • [25] TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN
    KIRCHNER, H
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1987, 129 (17): : 303 - 305
  • [26] EFFECT OF TUMOR-NECROSIS-FACTOR ON CEREBRAL ARTERIAL TONE
    AZIN, AL
    MITAGVARIYA, NP
    MEDVEDEV, VG
    BARATASHVILI, IK
    BARYBIN, AS
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1990, 110 (08) : 1001 - 1004
  • [27] EFFECT OF INTERMITTENT HYPOXIA ON THE PRODUCTION OF TUMOR-NECROSIS-FACTOR
    BAYASI, G
    KRUSE, JA
    DUBAYBO, BA
    GREVILLE, HW
    CLINICAL RESEARCH, 1992, 40 (02): : A411 - A411
  • [28] TUMOR-NECROSIS-FACTOR AND AIDS
    KOBAYASHI, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1993, 113 (01): : 1 - 18
  • [29] IMMUNOMODULATION BY TUMOR-NECROSIS-FACTOR
    HORI, K
    EHRKE, MJ
    MIHICH, E
    MOLECULAR AND CELLULAR NETWORKS FOR CANCER THERAPY, 1989, 857 : 75 - 79
  • [30] TUMOR-NECROSIS-FACTOR - AN OVERVIEW
    MAURY, CPJ
    ACTA MEDICA SCANDINAVICA, 1986, 220 (05): : 387 - 394